Cholinergic antagonism of methylphenidate-induced stereotyped behavior. 1972

D S Janowksy, and M K el-Yousef, and J M Davis, and H J Sekerke

UI MeSH Term Description Entries
D008297 Male Males
D008774 Methylphenidate A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE. Centedrin,Concerta,Daytrana,Equasym,Metadate,Methylin,Methylphenidate Hydrochloride,Phenidylate,Ritalin,Ritalin-SR,Ritaline,Tsentedrin,Hydrochloride, Methylphenidate,Ritalin SR
D009388 Neostigmine A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier. Synstigmin,Neostigmine Bromide,Neostigmine Methylsulfate,Polstigmine,Proserine,Prostigmin,Prostigmine,Prozerin,Syntostigmine,Bromide, Neostigmine,Methylsulfate, Neostigmine
D010830 Physostigmine A cholinesterase inhibitor that is rapidly absorbed through membranes. It can be applied topically to the conjunctiva. It also can cross the blood-brain barrier and is used when central nervous system effects are desired, as in the treatment of severe anticholinergic toxicity. Eserine
D011292 Premedication Preliminary administration of a drug preceding a diagnostic, therapeutic, or surgical procedure. The commonest types of premedication are antibiotics (ANTIBIOTIC PROPHYLAXIS) and anti-anxiety agents. It does not include PREANESTHETIC MEDICATION. Premedications
D011605 Psychoses, Substance-Induced Psychotic organic mental disorders resulting from the toxic effect of drugs and chemicals or other harmful substance. Psychoses, Drug,Psychoses, Toxic,Substance-Induced Psychoses,Toxic Psychoses,Drug Psychoses,Psychoses, Substance Induced,Substance Induced Psychoses
D004336 Drug Antagonism Phenomena and pharmaceutics of compounds that inhibit the function of agonists (DRUG AGONISM) and inverse agonists (DRUG INVERSE AGONISM) for a specific receptor. On their own, antagonists produce no effect by themselves to a receptor, and are said to have neither intrinsic activity nor efficacy. Antagonism, Drug,Antagonisms, Drug,Drug Antagonisms
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001522 Behavior, Animal The observable response an animal makes to any situation. Autotomy Animal,Animal Behavior,Animal Behaviors

Related Publications

D S Janowksy, and M K el-Yousef, and J M Davis, and H J Sekerke
January 1972, Acta pharmacologica et toxicologica,
D S Janowksy, and M K el-Yousef, and J M Davis, and H J Sekerke
January 1980, Psychopharmacology,
D S Janowksy, and M K el-Yousef, and J M Davis, and H J Sekerke
December 1978, European journal of pharmacology,
D S Janowksy, and M K el-Yousef, and J M Davis, and H J Sekerke
November 1972, Journal of the neurological sciences,
D S Janowksy, and M K el-Yousef, and J M Davis, and H J Sekerke
July 1981, Neuropharmacology,
D S Janowksy, and M K el-Yousef, and J M Davis, and H J Sekerke
April 1978, The Journal of pharmacy and pharmacology,
D S Janowksy, and M K el-Yousef, and J M Davis, and H J Sekerke
January 1977, Experientia,
D S Janowksy, and M K el-Yousef, and J M Davis, and H J Sekerke
January 1978, Communications in psychopharmacology,
D S Janowksy, and M K el-Yousef, and J M Davis, and H J Sekerke
October 1997, Pharmacology, biochemistry, and behavior,
D S Janowksy, and M K el-Yousef, and J M Davis, and H J Sekerke
June 1979, Life sciences,
Copied contents to your clipboard!